Literature DB >> 33679024

Low dose aspirin is effective in preventing venous thromboembolism in patients undergoing primary total knee arthroplasty.

David B Merkow1, Alex Tang1, Richard Iorio2, James D Slover1, Joseph A Bosco1, Ran Schwarzkopf1.   

Abstract

INTRODUCTION: Venous thromboembolism (VTE) is a known complication after total knee arthroplasty (TKA) with well-established morbidity, mortality, and significant healthcare expenditure. However, no standard form of prophylaxis against VTE currently exists.
METHODS: A retrospective review was performed identifying 12,866 TKA cases and post-operative VTE events using either 325 mg aspirin or 81 mg aspirin twice daily (BID).
RESULTS: 133 VTE cases were diagnosed of the 9413 TKA on 325 mg aspirin BID compared to 8 VTE cases out of 3453 TKA on 81 mg aspirin BID (1.41% vs. 0.23%, p < 0.001).
CONCLUSION: 81 mg aspirin BID significantly improved post-operative VTE rates over 325 mg aspirin BID.
© 2021 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aspirin; Deep vein thrombosis; Pulmonary embolism; Total knee arthroplasty; Venous thromboembolism

Year:  2021        PMID: 33679024      PMCID: PMC7902281          DOI: 10.1016/j.jor.2021.02.005

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  13 in total

1.  AAOS clinical practice guideline: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty.

Authors:  Michael A Mont; Joshua J Jacobs
Journal:  J Am Acad Orthop Surg       Date:  2011-12       Impact factor: 3.020

2.  Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prophylaxis Following Total Knee Arthroplasty.

Authors:  Mhamad Faour; Nicolas S Piuzzi; David P Brigati; Alison K Klika; Michael A Mont; Wael K Barsoum; Carlos A Higuera
Journal:  J Arthroplasty       Date:  2018-03-08       Impact factor: 4.757

3.  American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty.

Authors:  Norman A Johanson; Paul F Lachiewicz; Jay R Lieberman; Paul A Lotke; Javad Parvizi; Vincent Pellegrini; Theodore A Stringer; Paul Tornetta; Robert H Haralson; William C Watters
Journal:  J Bone Joint Surg Am       Date:  2009-07       Impact factor: 5.284

4.  Arguments favoring low versus high dose aspirin in the prophylaxis of venous thromboembolism.

Authors:  Piet Borgdorff; Geert Jan Tangelder
Journal:  Thromb Res       Date:  2016-01-27       Impact factor: 3.944

5.  Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty: A Preliminary Analysis.

Authors:  Javad Parvizi; Ronald Huang; Camilo Restrepo; Antonia F Chen; Matthew S Austin; William J Hozack; Jess H Lonner
Journal:  J Bone Joint Surg Am       Date:  2017-01-18       Impact factor: 5.284

6.  The incidence of deep vein thrombosis after cementless and cemented knee replacement.

Authors:  Y H Kim
Journal:  J Bone Joint Surg Br       Date:  1990-09

7.  The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.

Authors:  Alisina Shahi; Antonia F Chen; Timothy L Tan; Mitchell G Maltenfort; Fatih Kucukdurmaz; Javad Parvizi
Journal:  J Arthroplasty       Date:  2016-10-21       Impact factor: 4.757

8.  Recent Korean perspective of deep vein thrombosis after total knee arthroplasty.

Authors:  Kang-Il Kim; Kye-Youl Cho; Wook Jin; Sumit S Khurana; Dae-Kyung Bae
Journal:  J Arthroplasty       Date:  2011-04-06       Impact factor: 4.757

9.  Thromboembolic disease in patients undergoing total knee replacement.

Authors:  R McKenna; F Bachmann; S P Kaushal; J O Galante
Journal:  J Bone Joint Surg Am       Date:  1976-10       Impact factor: 5.284

10.  Risk-Stratified Venous Thromboembolism Prophylaxis After Total Joint Arthroplasty: Aspirin and Sequential Pneumatic Compression Devices vs Aggressive Chemoprophylaxis.

Authors:  Khalid Odeh; James Doran; Stephen Yu; Nicholas Bolz; Joseph Bosco; Richard Iorio
Journal:  J Arthroplasty       Date:  2016-03-16       Impact factor: 4.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.